AU2001296799A1 - Benzimidazole and indole derivatives as crf receptor modulators - Google Patents
Benzimidazole and indole derivatives as crf receptor modulatorsInfo
- Publication number
- AU2001296799A1 AU2001296799A1 AU2001296799A AU9679901A AU2001296799A1 AU 2001296799 A1 AU2001296799 A1 AU 2001296799A1 AU 2001296799 A AU2001296799 A AU 2001296799A AU 9679901 A AU9679901 A AU 9679901A AU 2001296799 A1 AU2001296799 A1 AU 2001296799A1
- Authority
- AU
- Australia
- Prior art keywords
- benzimidazole
- receptor modulators
- indole derivatives
- crf receptor
- crf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23871300P | 2000-10-06 | 2000-10-06 | |
US60238713 | 2000-10-06 | ||
PCT/US2001/031738 WO2002028839A1 (en) | 2000-10-06 | 2001-10-05 | Benzimidazole and indole derivatives as crf receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001296799A1 true AU2001296799A1 (en) | 2002-04-15 |
Family
ID=22899016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001296799A Abandoned AU2001296799A1 (en) | 2000-10-06 | 2001-10-05 | Benzimidazole and indole derivatives as crf receptor modulators |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030055037A1 (en) |
EP (1) | EP1322620A1 (en) |
JP (1) | JP2004510765A (en) |
KR (1) | KR20030060904A (en) |
AU (1) | AU2001296799A1 (en) |
CA (1) | CA2425185A1 (en) |
MX (1) | MXPA03003039A (en) |
WO (1) | WO2002028839A1 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8535601A1 (en) | 2000-12-21 | 2002-11-28 | Pfizer | BENZIMIDAZOL AND PIRIDILIMIDAZOL DERIVATIVES AS LIGANDOS FOR GABAA |
DE10159922A1 (en) * | 2001-12-06 | 2003-06-26 | Gruenenthal Gmbh | Substituted 2-pyrrolidin-2-yl-1H-indole derivatives |
EP1465635A4 (en) | 2002-01-10 | 2005-04-13 | Neurogen Corp | Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
CA2472470A1 (en) | 2002-01-10 | 2003-07-24 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
EP1753723B1 (en) | 2004-05-21 | 2008-08-13 | Novartis Vaccines and Diagnostics, Inc. | Substituted quinoline derivatives as mitotic kinesin inhibitors |
KR101170925B1 (en) | 2004-06-18 | 2012-08-07 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | N-1-1-benzyl-4-phenyl-1h-imidazol-2-yl-2,2-dimethylpropylbenzamide derivatives and related compounds as kinesin spindle protein ksp inhibitors for the treatment of cancer |
US7271271B2 (en) * | 2004-06-28 | 2007-09-18 | Amgen Sf, Llc | Imidazolo-related compounds, compositions and methods for their use |
KR100560132B1 (en) * | 2004-09-20 | 2006-03-13 | 주식회사 나인테크 | Soft water body shower of auto regenerating |
JP2008517057A (en) | 2004-10-19 | 2008-05-22 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | Indole and benzimidazole derivatives |
WO2007002701A2 (en) | 2005-06-27 | 2007-01-04 | Amgen Inc. | Anti-inflammatory aryl nitrile compounds |
EP1961745A1 (en) * | 2005-12-12 | 2008-08-27 | Ono Pharmaceutical Co., Ltd. | Bicyclic heterocyclic compound |
US20100056515A1 (en) * | 2006-10-25 | 2010-03-04 | Kazuyoshi Aso | Benzimidazole compounds |
KR20090081020A (en) | 2006-11-13 | 2009-07-27 | 노파르티스 아게 | Substituted pyrazole and triazole compounds as ksp inhibitors |
MX2009007260A (en) | 2007-01-05 | 2009-07-10 | Novartis Ag | Cyclized derivatives as eg-5 inhibitors. |
AU2009302493B2 (en) * | 2008-10-08 | 2015-04-09 | Cephalon Llc | Processes for the preparation of bendamustine |
RU2518073C2 (en) | 2008-12-26 | 2014-06-10 | ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. | Novel bicyclic heterocyclic compound |
EP2513113B1 (en) | 2009-12-18 | 2018-08-01 | Idenix Pharmaceuticals LLC | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
JP5667934B2 (en) * | 2010-06-28 | 2015-02-12 | 大日本住友製薬株式会社 | Pharmaceuticals comprising novel bicyclic heterocyclic compounds |
JP6002785B2 (en) * | 2012-02-03 | 2016-10-05 | ファイザー・インク | Benzimidazole and imidazopyridine derivatives as sodium channel modulators |
SG11201408004SA (en) * | 2012-06-04 | 2015-01-29 | Actelion Pharmaceuticals Ltd | Benzimidazole-proline derivatives |
CA2929423C (en) | 2013-12-03 | 2021-12-07 | Actelion Pharmaceuticals Ltd | Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1 ,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists |
UA119151C2 (en) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1 h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist |
AU2014358766B2 (en) | 2013-12-04 | 2019-01-17 | Idorsia Pharmaceuticals Ltd | Use of benzimidazole-proline derivatives |
GB201617630D0 (en) | 2016-10-18 | 2016-11-30 | Cellcentric Ltd | Pharmaceutical compounds |
GB201806320D0 (en) | 2018-04-18 | 2018-05-30 | Cellcentric Ltd | Process |
EP3824887A4 (en) * | 2018-07-19 | 2022-04-13 | Sumitomo Dainippon Pharma Co., Ltd. | Medicinal preparation for external use |
CN111004213B (en) * | 2019-12-26 | 2021-07-20 | 北京欣奕华科技有限公司 | Organic electroluminescent compound and application thereof |
BR112023022763A2 (en) | 2021-05-06 | 2024-01-02 | Bayer Ag | CANCELLED IMMIDAZOLES REPLACED BY ALKYLAMIDE AND THEIR USE AS INSECTICIDES |
CN115925699B (en) * | 2022-02-25 | 2023-10-03 | 南京知和医药科技有限公司 | Fused ring compound with analgesic activity and preparation method and application thereof |
WO2023248871A1 (en) * | 2022-06-20 | 2023-12-28 | 日本曹達株式会社 | Heteroaryl compound and pest control agent |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5955613A (en) * | 1995-10-13 | 1999-09-21 | Neurogen Corporation | Certain pyrrolopyridine derivatives; novel CRF1 specific ligands |
AU9025898A (en) * | 1997-08-21 | 1999-03-08 | American Home Products Corporation | Solid phase synthesis of 2,3-disubstituted indole compounds |
EP1165519A1 (en) * | 1999-04-02 | 2002-01-02 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics |
AU4055300A (en) * | 1999-04-02 | 2000-10-23 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of Bradykinin B2 receptors |
AU3931400A (en) * | 1999-04-02 | 2000-10-23 | Neurogen Corporation | N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators |
WO2000059905A1 (en) * | 1999-04-02 | 2000-10-12 | Neurogen Corporation | ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
DE60029235T2 (en) * | 1999-10-08 | 2007-06-14 | Affinium Pharmaceuticals, Inc., Toronto | FAB I INHIBITORS |
ATE294578T1 (en) * | 1999-10-08 | 2005-05-15 | Affinium Pharm Inc | FAB I HEMMER |
DE60120661T2 (en) * | 2000-03-27 | 2007-07-05 | Applied Research Systems Ars Holding N.V. | PHARMACEUTICALLY ACTIVE PYRROLIDINE DERIVATIVES AS BAX INHIBITORS |
-
2001
- 2001-10-05 CA CA002425185A patent/CA2425185A1/en not_active Abandoned
- 2001-10-05 WO PCT/US2001/031738 patent/WO2002028839A1/en not_active Application Discontinuation
- 2001-10-05 AU AU2001296799A patent/AU2001296799A1/en not_active Abandoned
- 2001-10-05 MX MXPA03003039A patent/MXPA03003039A/en unknown
- 2001-10-05 EP EP01977701A patent/EP1322620A1/en not_active Withdrawn
- 2001-10-05 KR KR10-2003-7004874A patent/KR20030060904A/en not_active Application Discontinuation
- 2001-10-05 JP JP2002532425A patent/JP2004510765A/en active Pending
- 2001-10-05 US US09/972,786 patent/US20030055037A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2004510765A (en) | 2004-04-08 |
WO2002028839A1 (en) | 2002-04-11 |
MXPA03003039A (en) | 2003-10-15 |
US20030055037A1 (en) | 2003-03-20 |
KR20030060904A (en) | 2003-07-16 |
CA2425185A1 (en) | 2002-04-11 |
EP1322620A1 (en) | 2003-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001296799A1 (en) | Benzimidazole and indole derivatives as crf receptor modulators | |
AU7314200A (en) | Benzimidazole derivatives | |
AU6000900A (en) | Carbazole derivatives and their use as neuropeptide y5 receptor ligands | |
AU2001264877A1 (en) | 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators | |
SI2233483T1 (en) | Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation. | |
AU1573201A (en) | Indole-3-carbinol (i3c) derivatives | |
EP1223929A4 (en) | Cannabimimetic indole derivatives | |
HUP0204029A3 (en) | Triphenylalkene derivatives and their use as selective estrogen receptor modulators | |
AU2002217287A1 (en) | Benzo(f) isoindol derivatives and their use as ep4 receptor ligands | |
AU2002222001A1 (en) | 3-arylindole derivatives and their use as CB2 receptor agonists | |
AU2001246671A1 (en) | Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands | |
AU2002224038A1 (en) | Benzimidazole derivatives | |
AU2001231664A1 (en) | Indol-3-yl derivatives | |
AU5633300A (en) | Indole compounds | |
AU5901900A (en) | Indole and indazole urea-peptoids as thrombin receptor antagonists | |
AU8664701A (en) | Oxindole derivatives | |
AU2001289758A1 (en) | Novel indole derivatives and their use as medicaments | |
IL130169A0 (en) | Indole derivatives | |
AU2001295455A1 (en) | Indoline derivatives as 5ht2c antagonists | |
HUP0202479A3 (en) | Indole derivatives | |
IL150336A0 (en) | Novel indole derivatives | |
AU7963300A (en) | Novel bipyridyl derivatives | |
AU2709001A (en) | Substituted tryptophan derivatives | |
AU2002364590A1 (en) | Hydroxylated indole derivatives and uses thereof | |
AU5633800A (en) | Indole compounds |